Table 2 Univariate and multivariate analysis of factors associated with overall survival
Clinical variable | Subset | Hazard ratio (95% CI) | P -value |
|---|---|---|---|
Univariate analysis | |||
Histology | Others versus mucinous versus serious | 0.672 (0.426–1.058) | 0.086 |
FIGO stage | III/IV versus I/II | 3.905 (2.439–6.252) | <0.001 |
Differentiation | Poor versus moderate versus well | 1.701 (1.326–2.181) | <0.001 |
Cytoreductive surgery | Suboptimal cytoreduction versus optimal cytoreduction | 3.302 (2.032–5.364) | <0.001 |
Expression of KPNA2 | High versus low | 2.404 (1.563–3.697) | <0.001 |
Multivariate analysis | |||
FIGO stage | III/IV versus I/II | 3.570 (1.984–6.424) | <0.001 |
Cytoreductive surgery | Suboptimal cytoreduction versus optimal cytoreduction | 1.819 (1.096–3.018) | 0.021 |
Expression of KPNA2 | High versus low | 1.832 (1.137–2.951) | 0.013 |
